CAPTRUST Financial Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,107
| Closed | -$217K | – | 2372 |
|
|
2024
Q3 | $217K | Sell |
3,107
-1,227
| -28% | -$85.7K | ﹤0.01% | 2082 |
|
|
2024
Q2 | $281K | Buy |
4,334
+74
| +2% | +$4.8K | ﹤0.01% | 1846 |
|
|
2024
Q1 | $276K | Buy |
4,260
+1,138
| +36% | +$73.6K | ﹤0.01% | 1821 |
|
|
2023
Q4 | $206K | Sell |
3,122
-1,027
| -25% | -$67.6K | ﹤0.01% | 2384 |
|
|
2023
Q3 | $237K | Sell |
4,149
-59
| -1% | -$3.37K | ﹤0.01% | 2175 |
|
|
2023
Q2 | $258K | Buy |
+4,208
| New | +$258K | ﹤0.01% | 2085 |
|
|
2022
Q3 | – | Sell |
-1,054
| Closed | -$61K | – | 3438 |
|
|
2022
Q2 | $61K | Hold |
1,054
| – | – | ﹤0.01% | 2591 |
|
|
2022
Q1 | $65K | Hold |
1,054
| – | – | ﹤0.01% | 2600 |
|
|
2021
Q4 | $75K | Hold |
1,054
| – | – | ﹤0.01% | 2367 |
|
|
2021
Q3 | $79K | Hold |
1,054
| – | – | ﹤0.01% | 2260 |
|
|
2021
Q2 | $82K | Hold |
1,054
| – | – | ﹤0.01% | 2178 |
|
|
2021
Q1 | $78K | Hold |
1,054
| – | – | ﹤0.01% | 2134 |
|
|
2020
Q4 | $74K | Sell |
1,054
-107
| -9% | -$7.51K | ﹤0.01% | 1656 |
|
|
2020
Q3 | $67K | Hold |
1,161
| – | – | ﹤0.01% | 1529 |
|
|
2020
Q2 | $68K | Buy |
+1,161
| New | +$68K | ﹤0.01% | 1500 |
|
|
2019
Q4 | – | Sell |
-250
| Closed | -$12K | – | 1561 |
|
|
2019
Q3 | $12K | Hold |
250
| – | – | ﹤0.01% | 1447 |
|
|
2019
Q2 | $13K | Hold |
250
| – | – | ﹤0.01% | 1430 |
|
|
2019
Q1 | $14K | Hold |
250
| – | – | ﹤0.01% | 1296 |
|
|
2018
Q4 | $12K | Hold |
250
| – | – | ﹤0.01% | 1177 |
|
|
2018
Q3 | $15K | Hold |
250
| – | – | ﹤0.01% | 1108 |
|
|
2018
Q2 | $14K | Hold |
250
| – | – | ﹤0.01% | 1072 |
|
|
2018
Q1 | $12K | Hold |
250
| – | – | ﹤0.01% | 986 |
|
|
2017
Q4 | $12K | Hold |
250
| – | – | ﹤0.01% | 948 |
|
|
2017
Q3 | $12K | Buy |
+250
| New | +$12K | ﹤0.01% | 421 |
|